Improving Rates of Diagnostic Colonoscopy in Native Americans
Part of paid clinical trials in Oklahoma City, Oklahoma.
- Sponsor
- University of Oklahoma
- Study ID
- NCT07115875
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- CRC (Colorectal Cancer)
- CRC Screening
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Digital Outreach — OTHERDigital outreach interventions through focus groups. The study is based on narrative interventions that highlights culturally sensitive and values among Native American communities.
- In Person consultation — OTHERIn-Person Consultation will receive standard of care at IHS Lawton Hospital. Consultation includes a colonoscopy risk assessment (i.e., current medication use, risk of perforation and bleeding, ability to complete bowel prep).
Study Details
Colorectal cancer (CRC) is the second-leading cause of cancer death in both men and women in the United States. Compared to national averages, Native Americans (NA) endure a disproportionate burden of CRC incidence and CRC-specific mortality. The long-term goal of this collaboration is to enhance health equity through the reduction of CRC disparities in morbidity, mortality, stage-at-diagnosis, and survival among NA. To do so, the primary focus of these efforts has been to improve processes that increase uptake of home stool screening. The overall objective is to leverage these relationships and infrastructure to now focus on improving rates of timely diagnostic colonoscopy follow up after an abnormal home stool screening.
Key Dates
- Start date
- Dec 31, 2025
- Status verified
- Sep 2025
- Primary completion
- Jul 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 164 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- SCREENING
Arms
- Experimental: mHealth Outreach and Telehealth ConsultationThe investigators will disseminate mHealth Outreach, using SMS texts with culturally relevant language and short videos that include personal narratives of patients and high-status Tribal members, to increase motivation to a schedule a diagnostic colonoscopy. Second, the investigators will try and overcome one refractory structural barrier to completing a diagnostic colonoscopy among Cheyenne and Arapaho Tribal members through telehealth. Cheyenne and Arapaho patients are required to visit the colonoscopy clinical facilities for both a pre-procedure appointment and the actual procedure. This process requires two round trips to a colonoscopy facility located in Lawton, OK, which is over 90 miles from the Clinton Indian Health Center. As a result, the investigators have proposed to test whether offering the pre-procedure as a telehealth consultation will overcome this transportation barriers.
- Active Comparator: In Person ConsultationParticipants randomized to In-Person Consultation will receive standard of care at IHS Lawton Hospital. Consultation includes a colonoscopy risk assessment (i.e., current medication use, risk of perforation and bleeding, ability to complete bowel prep).
Primary Outcome Measure
Focus Group Strategy [ Time Frame: 6 months ]
Central Contacts
- Jordan Neil, PhD(405) 271-5046
- Adam Alexander, PhD(405) 271-5046
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| TSET Health Promotion Research Center | Oklahoma City | Oklahoma | 73104 |
Find similar trials in Oklahoma City, OK
Related Studies
- A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesPHASE1 · Recruiting · Kumquat Biosciences Inc. · Phoenix, Arizona
- Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in OklahomaRecruiting · University of Oklahoma · Oklahoma City, Oklahoma
- A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsPHASE1 · Recruiting · Alterome Therapeutics, Inc. · Orlando, Florida
- BBO-11818 in Adult Subjects With KRAS Mutant CancerPHASE1 · Recruiting · TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · Los Angeles, California